According to a Bloomberg Report, thousands are reportedly lining up for the opportunity to receive a brain implant from Neuralink, the neurotechnology company co-founded by Elon Musk. This enthusiasm persists despite the invasive nature of the procedure, which involves removing a portion of the skull to implant the device.

Neuralink, established in 2016, has ambitious plans to conduct human trials, aiming to operate on 11 individuals next year and expand to over 22,000 by 2030. The company's goals are not modest; it seeks to forge a new frontier where humans and machines can interact seamlessly, potentially allowing individuals to communicate or control games through thought alone. Initially, however, the focus is on aiding those with neurological conditions.

Elon Musk's Neuralink Could be Trialed in Humans in 2023. Here's What You Need to Know

The U.S. Food and Drug Administration (FDA) has greenlit Neuralink to begin human trials, a significant step forward after initial safety concerns. These concerns included the potential for the device's wires to shift within the brain or for the chip to overheat.